hey crewlcat care to comment on this?
“At AIRM, we are always looking to advance our science and pipeline with cutting edge
technologies and development techniques”, said Dr. Jaime Chaufty, Director, Research at
AIRM. “We believe Exopharm’s proprietary technology platforms may help us address some
of the challenges involved in the development and use of extracellular vesicles for
regenerative medicine.”
hey crewlcat care to comment on this?“At AIRM, we are always...
Add EX1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.933M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EX1 (ASX) Chart |
Day chart unavailable